DMAC

$10.77+7.70%visit website

DiaMedica Therapeutics Inc.

Market Cap

$581M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.94

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

15.1

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	6,437	6,699	7,987	8,153	29,276
Operating income	(9,033)	(9,213)	(10,482)	(10,498)	(39,226)
Pretax income	(8,614)	(8,730)	(10,035)	(10,132)	(37,511)
Income tax	6.0	10.0	7.0	7.0	30.0
Net income	(8,620)	(8,740)	(10,042)	(10,139)	(37,541)
EPS (basic) ($)	(0.17)		(0.19)	(0.19)	(0.72)
Weighted avg. shares (basic)	49,630		53,793	53,894

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 30 more quarters, back to Mar 2018, with Tormere Pro.

Corporate Events (8-K)

7 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 10, 2026 accepted 4:35 PM ET	2.02Earnings release	Document SEC ↗
May 21, 2026 accepted 4:30 PM ET	5.07Shareholder vote	Document SEC ↗
May 6, 2026 accepted 4:36 PM ET	2.02Earnings release	Document SEC ↗
Mar 31, 2026 accepted 6:40 PM ET	2.02Earnings release	Document SEC ↗
Jan 5, 2026 accepted 9:15 AM ET	8.01Other events	Document SEC ↗
Dec 18, 2025 accepted 8:45 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Nov 12, 2025 accepted 4:31 PM ET	2.02Earnings release	Document SEC ↗
Aug 12, 2025 accepted 5:27 PM ET	1.01Material agreement	Document SEC ↗
Aug 12, 2025 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
Aug 6, 2025 accepted 8:00 AM ET	5.02Officer / director change7.01Reg FD disclosure8.01Other events	Document SEC ↗